President Trump criticized federal funding for LGBTQ-related research, particularly an $8 million grant for studies deemed as making mice transgender, during a congressional address. This funding supported critical medical research related to HIV, asthma, infertility, and breast cancer. The administration terminated or delayed over 2,400 National Institutes of Health grants, which negatively impacted diverse health initiatives at a time of increased LGBTQ identification. These cuts threaten vital studies that benefit both LGBTQ and cisgender populations, with communities at risk of adverse health outcomes due to the loss of crucial research support.
The federal grants supported six research efforts funded by the National Institutes of Health that focused on HIV, asthma, infertility, breast cancer, and other pressing concerns.
Not all the administration's cuts to research budgets are aimed at individual scientists; some target an entire university, such as at Harvard.
The termination of LGBTQ-benefiting medical research comes at a time when more people are identifying as LGBTQ than ever before.
LGBTQ communities would be the prime beneficiaries of the studies involving so-called transgender mice, but the findings also had the potential to improve the health of cisgender women.
Collection
[
|
...
]